CR7795A - Tetralinos e indanes sustitutos - Google Patents
Tetralinos e indanes sustitutosInfo
- Publication number
- CR7795A CR7795A CR7795A CR7795A CR7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tetralinos
- indanes
- substitutes
- tetralin
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención tiene como caracteristica compuestos de tetralina e indano, composiciones que los contienen y métodos de uso de los mismos como moduladores del PPAR alfa, para tratar o inhibir la progresión de por ejemplo la diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41993502P | 2002-10-21 | 2002-10-21 | |
US49527003P | 2003-08-15 | 2003-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR7795A true CR7795A (es) | 2012-10-25 |
Family
ID=32179771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR7795A CR7795A (es) | 2002-10-21 | 2005-04-18 | Tetralinos e indanes sustitutos |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1569897A1 (es) |
JP (1) | JP2006503916A (es) |
KR (1) | KR20050055773A (es) |
AU (1) | AU2003277441B2 (es) |
BR (1) | BR0315596A (es) |
CA (1) | CA2502661A1 (es) |
CR (1) | CR7795A (es) |
EA (1) | EA009553B1 (es) |
EG (1) | EG24842A (es) |
HR (1) | HRP20050335A2 (es) |
MX (1) | MXPA05004191A (es) |
NO (1) | NO20052199L (es) |
NZ (1) | NZ539510A (es) |
PL (1) | PL376325A1 (es) |
RS (1) | RS20050318A (es) |
TW (1) | TW200418773A (es) |
WO (1) | WO2004037778A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60327543D1 (de) * | 2002-10-21 | 2009-06-18 | Janssen Pharmaceutica Nv | Substituierte tetraline und indane und ihre verwendung |
EA200500517A1 (ru) * | 2002-10-21 | 2005-10-27 | Янссен Фармацевтика Н. В. | Лечение синдрома х замещёнными тетралинами и инданами |
AR048931A1 (es) * | 2004-04-21 | 2006-06-14 | Janssen Pharmaceutica Nv | Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis |
EP1804785A2 (en) * | 2004-10-27 | 2007-07-11 | Neurogen Corporation | Diaryl ureas as cb1 antagonists |
EA015717B1 (ru) | 2005-12-22 | 2011-10-31 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Феноксиуксусные кислоты в качестве активаторов ppar дельта |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
WO2001060807A1 (en) * | 2000-02-18 | 2001-08-23 | Merck & Co. Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
EE200300140A (et) * | 2000-10-05 | 2003-08-15 | Bayer Aktiengesellschaft | PPAR-alfat aktiveerivate omadustega propaanhappe derivaadid |
JPWO2002044129A1 (ja) * | 2000-11-29 | 2004-04-02 | 杏林製薬株式会社 | 置換カルボン酸誘導体 |
WO2002046146A1 (fr) * | 2000-12-05 | 2002-06-13 | Kyorin Pharmaceutical Co., Ltd. | Derives d'acide carboxylique substitues |
US7091225B2 (en) * | 2000-12-20 | 2006-08-15 | Smithkline Beecham Corporation | Substituted oxazoles and thiazoles as hPPAR alpha agonists |
CA2438492A1 (en) * | 2001-02-15 | 2002-08-22 | Pfizer Products Inc. | Proliferative activator receptor (ppar) compounds |
UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
DE60327543D1 (de) * | 2002-10-21 | 2009-06-18 | Janssen Pharmaceutica Nv | Substituierte tetraline und indane und ihre verwendung |
EA200500517A1 (ru) * | 2002-10-21 | 2005-10-27 | Янссен Фармацевтика Н. В. | Лечение синдрома х замещёнными тетралинами и инданами |
-
2003
- 2003-10-17 WO PCT/US2003/033090 patent/WO2004037778A1/en active Application Filing
- 2003-10-17 CA CA002502661A patent/CA2502661A1/en not_active Withdrawn
- 2003-10-17 EA EA200500515A patent/EA009553B1/ru not_active IP Right Cessation
- 2003-10-17 RS YUP-2005/0318A patent/RS20050318A/sr unknown
- 2003-10-17 BR BR0315596-0A patent/BR0315596A/pt not_active IP Right Cessation
- 2003-10-17 JP JP2005501629A patent/JP2006503916A/ja not_active Withdrawn
- 2003-10-17 AU AU2003277441A patent/AU2003277441B2/en not_active Ceased
- 2003-10-17 MX MXPA05004191A patent/MXPA05004191A/es active IP Right Grant
- 2003-10-17 KR KR1020057006795A patent/KR20050055773A/ko not_active Application Discontinuation
- 2003-10-17 PL PL03376325A patent/PL376325A1/xx not_active Application Discontinuation
- 2003-10-17 NZ NZ539510A patent/NZ539510A/en not_active IP Right Cessation
- 2003-10-17 EP EP03809577A patent/EP1569897A1/en not_active Withdrawn
- 2003-10-21 TW TW092129192A patent/TW200418773A/zh unknown
-
2005
- 2005-04-14 HR HR20050335A patent/HRP20050335A2/hr not_active Application Discontinuation
- 2005-04-18 CR CR7795A patent/CR7795A/es not_active Application Discontinuation
- 2005-04-20 EG EGNA2005000152 patent/EG24842A/xx active
- 2005-05-04 NO NO20052199A patent/NO20052199L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EG24842A (en) | 2010-10-13 |
AU2003277441B2 (en) | 2009-05-07 |
PL376325A1 (en) | 2005-12-27 |
BR0315596A (pt) | 2005-09-06 |
EP1569897A1 (en) | 2005-09-07 |
EA009553B1 (ru) | 2008-02-28 |
KR20050055773A (ko) | 2005-06-13 |
NO20052199L (no) | 2005-06-24 |
WO2004037778A1 (en) | 2004-05-06 |
MXPA05004191A (es) | 2006-01-27 |
JP2006503916A (ja) | 2006-02-02 |
TW200418773A (en) | 2004-10-01 |
HRP20050335A2 (en) | 2006-05-31 |
AU2003277441A1 (en) | 2004-05-13 |
CA2502661A1 (en) | 2004-05-06 |
RS20050318A (en) | 2007-09-21 |
EA200500515A1 (ru) | 2005-10-27 |
NZ539510A (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018002099A1 (es) | Compuestos de piperidina sustituido y su uso | |
UY30846A1 (es) | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos | |
UY37589A (es) | COMPUESTOS MODULADORES DEL RECEPTOR DE HIDROCARBUROS ARÍLICOS (AhR) | |
UY37590A (es) | COMPUESTOS MODULADORES DEL RECEPTOR DE HIDROCARBUROS ARÍLICOS (AhR) | |
CL2009000309A1 (es) | Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2. | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
UY28731A1 (es) | Compuestos quimicos | |
ECSP066536A (es) | Derivados de acidos fenoxiaceticos utiles como agonistas dobles dereceptor activado por proliferador de peroxisoma | |
ECSP21026021A (es) | Moduladores de la expresión de pnpla3 | |
ECSP077319A (es) | Acidos 4-((fenoxialquil)tio)-fenoxiaceticos, y analogos de los mismos | |
DOP2006000175A (es) | Heterociclos de 1,4-dihidropiridina condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
PA8577201A1 (es) | 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b | |
CY1110326T1 (el) | Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους | |
CR7795A (es) | Tetralinos e indanes sustitutos | |
CR9054A (es) | Ácidos 4-((fenoxialquil)tio)-fenoxiaceticos y análogos | |
CL2007002387A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de artritis y dolor. | |
AR047553A1 (es) | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina | |
CL2009000599A1 (es) | Compuestos derivados de 4,5-dihidro-1h-pirazol(4,3-g)benzotiazol sustituidos; composicion farmaceutica; utiles para el tratamiento y prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes, entre otras. | |
RS20050319A (en) | Treating syndrome x with substituted tetralins and indanes | |
UY38472A (es) | Moduladores de la expresión de foxp3 | |
CL2016002283A1 (es) | Uso de una composición que comprende por lo menos tres diferentes compuestos seleccionados del grupo que consiste de 5’-metilselenoadenosina, se-adenosil-l-homocisteína, gama-glutamil-metilseleno-cisteína, un compuesto de la fórmula (i), (ii) o (iii) definidas y un portador para tratar la diabetes; composición. | |
AR117079A1 (es) | Moduladores de la expresión de foxp3 | |
GT200700006A (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
ECSP066628A (es) | Indol-o-glucosidos sustituidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |